Clinical trial
Resveratrol for Patients With Colon Cancer
NCT00256334 · University of California, Irvine, Other · Completed
Key facts
| NCT number | NCT00256334 |
|---|---|
| Title | Resveratrol for Patients With Colon Cancer |
| Official title | Resveratrol for Patients With Colon Cancer |
| Lead sponsor | University of California, Irvine, Other |
| Collaborators | University of California, Los Angeles |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Colon Cancer, Cancer |
| Intervention type | Drug |
| Interventions | Resveratrol |
| Enrollment | 11 |
| Start date | Jul 1, 2005 |
| Primary completion | Dec 1, 2008 |
| Completion | Apr 1, 2009 |
| First posted | Nov 21, 2005 |
| Last update posted | Jun 20, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: